Recursion Pharmaceuticals EBIT per Employee

EBIT per Employee of Recursion Pharmaceuticals is -1.30 M USD in 2026.

EBIT per Employee of Recursion Pharmaceuticals changed from -958,008.00 USD to -1.30 M USD, representing a 35.31% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee Recursion Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Recursion Pharmaceuticals historically and in real time.